Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OM-85 for prevention of respiratory infections in high-risk elderly residents
2024-513592-41-00Phase 4Authorised
- Sponsor
- Fondazione Policlinico Universitario Campus Bio-Medico
- Start
- Dec 2024
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Airways Infection comparing OM-85 with Placebo (2 arms). Planned start Dec 2024; status: authorised.
02
Drugs
OM-85
03
Conditions
Airways Infection
Beyond the preview
Go deeper on 2024-513592-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513592-41-00.